Clinical Trial Update: Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68) [Phase 4]

View source ↗

Summary

Phase 4 TIMI 68 trial evaluating dapagliflozin for cardiovascular events in acute heart failure has completed; the snippet notes completion but does not present…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: The TIMI Study Group | Conditions: Acute Heart Failure, Heart Failure | Phase 4 | Status: COMPLETED